Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1a
Ontology highlight
ABSTRACT: Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1a
PROVIDER: PRJNA999509 | ENA |
REPOSITORIES: ENA
ACCESS DATA